Literature DB >> 1308000

[Epidemiology of mycetoma in Mexico: study of 2105 cases].

R López Martínez1, L J Méndez Tovar, P Lavalle, O Welsh, A Saúl, E Macotela Ruíz.   

Abstract

A survey was carried out in Mexico to determine the incidence and epidemiological characteristics of mycetoma. Data was collected from a total of 2105 cases of mycetoma throughout a 30 year period (1956-1985), with an average incidence of 70 cases per year. Results showed a sex distribution of 76.1% male and 23.9% females. Age distribution indicated a 35% between 16 to 30 and 23% between 31 to 40 year old population. Most cases occurred in land-workers (60.2%) and in housewives with rural residence (21.3%). Lesions occurred most frequently in lower limbs (64.1%), trunk (17.4%) and upper limbs (13.6%). The geographic distribution within Mexico revealed that the States with the highest incidence were: Jalisco, Nuevo León, San Luis Potosi, Morelos and Guerrero The predominant etiologic agents found 97.8% corresponded to actinomycetes, from which Nocardia brasiliensis (86.6%) and Actinomadura madurae (10.2%) showed the higher frequency. Eumycetoma (2.2%) was due to Madurella grisea and M. mycetomatis in most cases.

Entities:  

Mesh:

Year:  1992        PMID: 1308000

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  40 in total

1.  Nocardia mexicana sp. nov., a new pathogen isolated from human mycetomas.

Authors:  Verónica Rodríguez-Nava; Andrée Couble; Claudie Molinard; Horacio Sandoval; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Adrian Rendon; Jorge Ocampo-Candiani; Oliverio Welsh; Victor M Velazquez-Moreno; Sung Hak Choi; Carmen Molina-Torres
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Complete genome sequence of Nocardia brasiliensis HUJEG-1.

Authors:  Lucio Vera-Cabrera; Rocio Ortiz-Lopez; Ramiro Elizondo-Gonzalez; Antonio Ali Perez-Maya; Jorge Ocampo-Candiani
Journal:  J Bacteriol       Date:  2012-05       Impact factor: 3.490

4.  Direct detection of Nocardia spp. in clinical samples by a rapid molecular method.

Authors:  Andrée Couble; Verónica Rodríguez-Nava; Michèle Pérouse de Montclos; Patrick Boiron; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Distribution of a Nocardia brasiliensis catalase gene fragment in members of the genera Nocardia, Gordona, and Rhodococcus.

Authors:  L Vera-Cabrera; W M Johnson; O Welsh; F L Resendiz-Uresti; M C Salinas-Carmona
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Actinomycetoma in arm disseminated to lung with grains of Nocardia brasiliensis with peripheral filaments.

Authors:  Bertha Muñoz-Hernández; María Cecilia Noyola; Gabriel Palma-Cortés; Dora Patricia Rosete; Miguel Angel Galván; María Eugenia Manjarrez
Journal:  Mycopathologia       Date:  2009-02-24       Impact factor: 2.574

7.  Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones.

Authors:  F Hernandez-Hernandez; R Lopez-Martinez; L J Mendez-Tovar; P Manzano-Gayosso
Journal:  Mycopathologia       Date:  1995-11       Impact factor: 2.574

8.  In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.

Authors:  Alejandra Daw-Garza; Oliverio Welsh; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2008-02-19       Impact factor: 5.191

Review 9.  Mycetomas in Iran: a review article.

Authors:  Ali Zarei Mahmoudabadi; Majid Zarrin
Journal:  Mycopathologia       Date:  2007-10-06       Impact factor: 2.574

10.  In vitro activities of new antimicrobials against Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Eva Gonzalez; Sung H Choi; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.